BI
BIOLQ.US Biolase Inc
- Market cap
- USD 3.66K
- P/E
- -
- P/B
- 0.77x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.
Is BIOLQ.US undervalued?
Graham numberThe Graham number of Biolase Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Biolase Inc fundamental analysis
No fundamental analysis for Biolase Inc yet.
Biolase Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Biolase Inc
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterl…
Full company profileBiolase Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Biolase Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 22.8M | 39.2M | 48.5M | 49.2M | 43.4M |
| Gross Profit | 6.17M | 16.5M | 15.9M | 16.7M | 16.4M |
| Operating Income | -18.5M | -16.1M | -25.3M | -17.9M | -11.3M |
| EBITDA | - | -13.5M | -25.3M | -15.4M | - |
| Net Income | -16.8M | -16.2M | -28.6M | -20.6M | -14.3M |
| EPS | -431 | -263 | -371 | -6.04 | -0.39 |
| Balance Sheet | |||||
| Total Assets | 41.0M | 55.3M | 38.2M | 35.1M | 27.2M |
| Total Liabilities | 31.0M | 30.1M | 33.3M | 35.3M | 32.5M |
| Shareholders' Equity | 10.0M | 25.2M | 4.89M | -247K | -5.23M |
| Cash & Short-term Investments | 17.6M | 30.0M | 4.18M | 6.57M | 3.44M |
| Cash Flow | |||||
| Operating Cash Flow | -12.8M | -16.7M | -26.8M | -14.1M | -14.9M |
| Capital Expenditure | 96.0K | 707K | 3.73M | 1.31M | 53.3K |
| Free Cash Flow | -12.9M | -17.4M | -30.5M | -15.4M | -14.9M |
| Ratios | |||||
| ROE | -167.8% | -64.1% | -585.7% | - | - |
| ROA | -41.0% | -29.2% | -75.0% | -58.8% | -52.4% |
| Net Profit Margin | -73.9% | -41.2% | -59.1% | -42.0% | -32.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Biolase Inc dividends
Biolase Inc has not paid dividends in the last 4 fiscal years.
Last stock split: 1:100 on Jul 28, 2023.
Who owns Biolase Inc
Ownership data of Biolase Inc is not available yet.
Biolase Inc company profile
- Company name
- Biolase Inc
- Ticker
- BIOLQ.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 157
- Fiscal year end
- December
- Address
- 27042 Towne Centre Drive, Foothill Ranch, CA, United States, 92610-2811
- Phone
- (949) 361-1200
- Website
- biolase.com
About Biolase Inc
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterlase (all-tissue) systems for cutting soft and hard tissue; and diode (soft-tissue) systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
Biolase Inc management
3- Mr. John R. BeaverPresident, CEO & Director · born 1961
- Mr. Steven SandorChief Operating Officer · born 1981
- Mr. Michael C. CarrollCorporate Secretary · born 1972